Sciensus launches CareTranscribe pilot project
Today Sciensus has announced the launch of a new pilot evaluating how Microsoft Dragon Copilot, with its AI capabilities, can be used within Sciensus’ home-based care workflows. The trial is part of the Sciensus initiative ‘CareTranscribe’ and focuses specifically on evaluating AI-generated note accuracy and documentation support. It will run initially across England and Scotland with patients receiving homecare support.
Understanding the patient experience
Hospital visits and clinical trials capture only part of the patient experience – they miss the nuances of how patients actually experience treatment in their daily lives. Our nurses conduct home visits for complex drug administration, patient education and ongoing support across specialty therapeutic areas. These conversations happen in a more relaxed, comfortable environment for patients which is more likely to naturally surface treatment context that wouldn’t be captured in traditional data collection.
Nurses identify treatment adherence patterns and barriers to compliance in real time, capture safety signals raised in natural conversation and uncover education needs that persist despite formal training. Perhaps most valuable are the practical realities of in-home clinical treatment, including device usability issues, storage challenges and daily-life factors that rarely surface in traditional data sources.
Until now, much of this contextual information has been difficult to capture systematically. Sciensus is broadly exploring how unstructured data, enriched with context from in-home clinical treatment, can enable insight-led collaboration with pharma and biotech partners to better understand patient behaviour and inform evidence generation and service design.
How CareTranscribe works
The pilot integrates Microsoft’s Dragon Copilot technology into our existing in-home clinical care services workflow, demonstrating how digital innovation can enhance clinical practice without disrupting nurse-patient relationships. During the pilot, Sciensus’ clinical nurse specialists working in the community will use Dragon Copilot to securely capture ambient audio from clinical conversations and automatically transform interactions into detailed notes and structured summaries while nurses remain fully present and focused on the patient. Nurses will review the information as a supportive input when completing Sciensus’ clinical evaluation forms. Nurses retain full control over clinical documentation, reviewing and validating all AI-generated content before finalising patient records.
The pilot operates within a robust governance framework that aligns with NHS information governance requirements and UK and EU legal standards. All patients provide informed consent with full transparency about data use and strict anonymisation protocols. The pilot is delivered in accordance with relevant Class I medical-device requirements.
From pilot to potential future programme
If this initial pilot demonstrates the value we anticipate, we will expand access to CareTranscribe across our entire UK in-home clinical care service. This represents a significant step in our commitment to operating at the forefront of technological innovation, constantly exploring how digital tools can amplify the quality of care we provide to patients. Every interaction our nurses have with patients generates valuable real-world evidence captured in natural settings – the patient voice, unfiltered and contextual, at a scale that traditional clinical data sources cannot match.
Insights drawn from the lived experience of patients managing complex conditions are invaluable. We are continuously working to leverage technology to gather and understand these insights, so we can shape future therapies, enhance patient support programmes and improve care delivery across complex conditions. The CareTranscribe pilot represents our commitment to responsible innovation that serves both our nurses and the patients they care for.
As Christian Tucat, CEO at Sciensus, notes: “Our nurses are at the heart of patient care and anything that gives them more time with their patients is a meaningful step forward. By working with Microsoft, we are leveraging responsible-AI technology to support our pharmaceutical partners in capturing aggregated and anonymised real-world data that can drive continued healthcare improvements. It’s a purposeful combination of human compassion and intelligent technology – all in service of better patient care.
